Paul Sanger interviewed Damian Spring, CEO of Santana Minerals Limited (ASX:SMI), to discuss the Bendigo gold project, which has recently been designated as a fast-track project. Damian highlighted the project's economic potential, projecting 1.1 million ounces of gold over ten years, which could generate significant export earnings and job creation in New Zealand. He mentioned ongoing environmental studies and a feasibility study set for release soon, emphasising the positive impact of rising gold prices on profitability and investor interest.
Copyright 2024 – Finance News Network
01 Sep 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook, discusses highlights from FY21, including growth in partners and transactions as the company's technology finds greater adoption and new markets.
22 Nov 2021 - Arovella Therapeutics Limited (ASX:ALA) CEO & Managing Director Dr Michael Baker provides an update on the company's invariant Natural Killer T (iNKT) cell platform and its oral spray delivery technology to treat cancer and conditions that affect the central nervous system.
21 Jun 2021 - BluGlass Limited (ASX:BLG) Executive Chair, James Walker and Chief Technology and Operations Officer, Dr Ian Mann discuss the company's laser diode production and its recent rights issue.
28 Feb 2022 - BHP Group Limited (ASX:BHP) CEO Mike Henry and CFO David Lamont provide a shareholder update with Gabrielle Notley, Head of Corporate Communications.
10 Oct 2023 - Andrew Worland - Managing Director and Chief Executive Officer - International Graphite (ASX:IG6) is building Australia’s capability in critical battery minerals and establishing a new ethical supply of battery anode graphite to support the global revolution in clean energy.
01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
03 Oct 2023 - Alex Hanly, CEO of Lithium Universe Limited (ASX:LU7), provides an update on the company's projects, discussing progress towards developing the Quebec Lithium Processing Hub.
10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
20 Nov 2019 - Ausbil Investment Management Chief Investment Officer, Paul Xiradis and Ausbil Head of ESG Research, Måns Carlsson-Sweeny, provide an update on the Ausbil Active Sustainable Equity fund’s performance, talk about what the fund looks for in businesses that fit the description of "sustainable", and discuss how these characteristics provide long-term above-market returns.
